CN Patent

CN107531675A — 治疗活性化合物及其使用方法

Assigned to Agios Pharmaceuticals Inc · Expires 2018-01-02 · 8y expired

What this patent protects

提供了可用于治疗癌症的2‑甲基‑1‑[(4‑[6‑(三氟甲基)吡啶‑2‑基]‑6‑{[2‑(三氟甲基)吡啶‑4‑基]氨基}‑1,3,5‑三嗪‑2‑基)氨基]丙‑2‑醇甲磺酸酯的晶型及治疗癌症的方法，所述方法包括向有此需要的对象施用所述化合物。

USPTO Abstract

提供了可用于治疗癌症的2‑甲基‑1‑[(4‑[6‑(三氟甲基)吡啶‑2‑基]‑6‑{[2‑(三氟甲基)吡啶‑4‑基]氨基}‑1,3,5‑三嗪‑2‑基)氨基]丙‑2‑醇甲磺酸酯的晶型及治疗癌症的方法，所述方法包括向有此需要的对象施用所述化合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN107531675A
Jurisdiction
CN
Classification
—
Expires
2018-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Agios Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.